The following decision was adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB (legal entity code 302564383, registered office address at Karlo Gustavo Emilio Manerheimo st. 8, LT-05131, Vilnius) (the “Company”) which was held on13-03-2026: 1. Regarding the approval of the Decision of 17 February 2026 of the Board of LITGRID AB to conclude agreements on the provision of humanitarian aid 1.1. To approve the Decision of 17 February 2026 of the Board of LITGRID to conclude humanitarian aid provision agreements with entities operating in Ukraine that meet the requirements of the Law on Development Cooperation and Humanitarian Aid of the Republic of Lithuania, and to approve the following essential terms and conditions of the humanitarian aid agreement: 1.1.1. Subject matter of the agreements – humanitarian aid to the...

SHENZHEN, CHINA, March 13, 2026 (GLOBE NEWSWIRE) — Lianhe Sowell International Group Ltd (Nasdaq: LHSW) (the “Company”), a provider of industrial machine vision products and solutions in China, today announced that it has signed a non-binding Memorandum of Understanding (MOU) for strategic cooperation with World Mobile Group Ltd, a global decentralized communications network operator. The MOU discussions were initiated and facilitated by OOKC Investment Holdings Group (“OOKC”), a global digital asset investment institution. OOKC will participate in the collaboration as a strategic facilitator and ecosystem architect, supporting the advancement of the potential collaboration. Under the cooperation framework of the MOU, the collaboration brings complementary expertise across technology, infrastructure, and capital markets together...

Company and Investor Mutually Agree to Terminate Previously Announced Strategic Private Placement ASHLAND, Ky., March 13, 2026 (GLOBE NEWSWIRE) — TX Rail Products, Inc, (“we, “ ”our,” ”us,” “TX Rail” or “Company”) (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced that previously disclosed strategic private placement financing has been terminated and will not proceed. As previously announced, on January 5, 2026, and as updated on January 16, 2026, we entered into a securities purchase agreement with an institutional accredited investor for the sale of 6,000,000 shares of our common stock at $0.30 per share for anticipated gross proceeds to us of approximately $1.8 million, along with an option for the investor to purchase...

Visit Nexentis at: www.nexentistech.com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) — Nexentis Technologies Inc. (NASDAQ: NXTS), (“Nexentis” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, is proud to announce the launch of its new corporate website at www.nexentistech.com. This digital milestone follows the company’s recent rebranding from N2OFF, Inc., and underscores its commitment to advancing mitochondrial biology for breakthroughs in precision oncology and inflammatory metabolic diseases. The newly launched website serves as a comprehensive hub for stakeholders, including investors, partners, and the scientific community, to explore Nexentis’ transformative platform. Key features include detailed insights into the...

Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and expansion of Akari’s ADC pipeline  Access the Akari CEO Corner here TAMPA, Fla. and LONDON, March 13, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today released a new CEO Corner segment featuring President and Chief Executive Officer Abizer Gaslightwala reflecting on his first year leading the Company and the strategic progress achieved during that time. Over the past year under Abizer Gaslightwala’s leadership, Akari Therapeutics has sharpened its strategic focus and advanced the development of its proprietary PH1 ADC payload platform. In the latest CEO Corner, Mr. Gaslightwala highlights...

13 March 2026 LEI: 2138003QW2ZAYZODBU23 LSE Code: 2UKS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE FTSE 100 2X DAILY SHORT SECURITIESISIN: IE00B94QKF15PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree FTSE 100 2x Daily Short Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser or transferee...